Central nervous system risk factors for sudden cardiac death.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001519:Behavior; D005117:Cardiac Complexes, Premature / Q000150:complications / Q000523:psychology; D002493:Central Nervous System Diseases / Q000150:complications* / Q000523:psychology; D003327:Coronary Disease / Q000150:complications / Q000401:mortality* / Q000523:psychology; D003645:Death, Sudden / Q000209:etiology*; D004285:Dogs; D004558:Electric Stimulation; D005221:Fatigue / Q000150:complications / Q000523:psychology; D000882:Haplorhini; D006801:Humans; D008688:Methacholine Compounds / Q000494:pharmacology; D009203:Myocardial Infarction / Q000150:complications / Q000523:psychology; D051381:Rats; D012306:Risk; D013315:Stress, Psychological / Q000150:complications / Q000193:education / Q000523:psychology; D013552:Swine; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014630:Vagus Nerve / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000150:complications / Q000209:etiology / Q000523:psychology
D000319:Adrenergic beta-Antagonists; D008688:Methacholine Compounds